logo

For the Inventor, By the Inventor

Randolph, NJ, United States of America

Gregori J Morriello

This inventor holds 29 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 17 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Merck Sharp + Dohme Corp., Merck + Co., Inc., Merck Sharp & Dohme LLC. Active years: 1996-2026.

USPTO Granted Patents = 29 

% Patents Active = 93.1

 

 

Average Co-Inventor Count = 6.3

ph-index = 9

Forward Citations = 233(Granted Patents)


Location History:

  • Belleville, NJ (US) (1996 - 2002)
  • Rahway, NJ (US) (2019)
  • Randolph, NJ (US) (2004 - 2024)

Company Filing History:

goldMedal16 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
silverMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents
bronzeMedal2 out of 67 
 
Merck Sharp & Dohme LLC
 patents
4. 1 out of 10 
 
Msd R&d (China) Co., Ltd.
 patents
5. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1996-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
LRRK2 Inhibitors
PDE2 Inhibitors
HIV Protease Inhibitors
Beta 3 Agonists
GPR119 Agonists
Chemokine Receptor Modulators
Anti-Hypercholesterolemic Compounds
Growth Hormone Release
Piperazine Derivatives
Pyrrolidine Derivatives
Tetrahydropyranyl Compounds
Indazole Derivatives
29 patents (USPTO):Explore Patents
1. 12570640 - 2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2026-03-10),
2. 12540131 - N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2026-02-03),
3. 12319671 - 1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2025-06-03),
4. 12030872 - N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof (2024-07-09),
5. 10647727 - Substituted pyrazolo/imidazolo bicyclic compounds as PDE2 inhibitors (2020-05-12),
6. 10357481 - Substituted triazolo bicyclic compounds as PDE2 inhibitors (2019-07-23),
7. 10138255 - Piperazine derivatives as HIV protease inhibitors (2018-11-27),
8. 9840478 - Piperazine derivatives as HIV protease inhibitors (2017-12-12),
9. 9186354 - Pyrrolidine derived β3 adrenergic receptor agonists (2015-11-17),
10. 9018224 - Substituted cyclopropyl compounds useful as GPR119 agonists (2015-04-28),
11. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment (2015-02-17),
12. 8933102 - Pyrrolidine derived β3 adrenergic receptor agonists (2015-01-13),
13. 8653260 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2014-02-18),
14. 8501786 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2013-08-06),
15. 8399480 - Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists (2013-03-19),

Title: The Innovative Journey of Gregori J Morriello

Introduction: Gregori J Morriello, a talented inventor hailing from Randolph, NJ, has made significant contributions to the field of technology with his creative and groundbreaking ideas.

Latest Patents: Gregori J Morriello holds several patents in various technological domains, showcasing his versatility and ingenuity in inventing new solutions to complex problems.

Career Highlights: Throughout his illustrious career, Gregori J Morriello has been recognized for his exceptional problem-solving skills and innovative thinking. His inventions have revolutionized the way we interact with technology on a daily basis.

Collaborations: Gregori J Morriello has collaborated with leading tech companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to the successful development of cutting-edge technologies.

Conclusion: In conclusion, Gregori J Morriello's passion for innovation and dedication to pushing the boundaries of technology have established him as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors to think outside the box and pursue their creative ideas relentlessly.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…